Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
Colorcon
Mallinckrodt
McKesson
Moodys
US Army
UBS
Cipla

Generated: July 17, 2018

DrugPatentWatch Database Preview

ATENOLOL; CHLORTHALIDONE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for atenolol; chlorthalidone and what is the scope of atenolol; chlorthalidone patent protection?

Atenolol; chlorthalidone
is the generic ingredient in three branded drugs marketed by Alvogen Malta, Mylan, Nostrum Labs, Pliva, Sun Pharm Industries, and Watson Labs, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-three drug master file entries for atenolol; chlorthalidone. Twelve suppliers are listed for this compound.
Pharmacology for ATENOLOL; CHLORTHALIDONE

US Patents and Regulatory Information for ATENOLOL; CHLORTHALIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen Malta ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 072302-001 May 31, 1990 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 073665-001 Jul 2, 1992 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pliva ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 074107-001 Sep 24, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Nostrum Labs ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 074404-001 May 14, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for ATENOLOL; CHLORTHALIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760-002 Jun 8, 1984 ➤ Sign Up ➤ Sign Up
Alvogen Malta TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760-002 Jun 8, 1984 ➤ Sign Up ➤ Sign Up
Alvogen Malta TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 ➤ Sign Up ➤ Sign Up
Alvogen Malta TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Teva
McKinsey
Cipla
Cerilliant
Dow
Colorcon
Covington
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.